Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease.
1. The insulin-like growth factor 1 (IGF1)-phosphoinositide 3-kinase (PI3-K) pathway is a critical regulator of cell and organ growth. 2. In the heart, the IGF1-PI3-K pathway induces physiological heart growth with preserved or enhanced cardiac function. 3. The present review specifically discusses the role of the IGF1-PI3-K pathway in the setting of heart disease. 4. Genetic mouse models have highlighted the beneficial effects of the IGF1-PI3-K pathway in the heart in a setting of disease. These include maintenance of contractile function, antifibrotic and anti-apoptotic actions, inhibition of signalling transducers activated in disease settings and regeneration.
McMullen
Julie R
JR
Baker Heart Research Institute, Melbourne, Victoria, Australia. Julie.mcmullen@baker.edu.au
D000818:Animals; D006331:Heart Diseases / Q000201:enzymology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000235:genetics / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism*
D007334:Insulin-Like Growth Factor I; D019869:Phosphatidylinositol 3-Kinases